Search Results

There are 15227 results for: content related to: Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures

  1. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 567–582, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2127

  2. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 689–699, Vincent Lo Re III, Joseph K. Lim, Matthew Bidwell Goetz, Janet Tate, Harini Bathulapalli, Marina B. Klein, David Rimland, Maria C. Rodriguez-Barradas, Adeel A. Butt, Cynthia L. Gibert, Sheldon T. Brown, Farah Kidwai, Cynthia Brandt, Zachariah Dorey-Stein, K. Rajender Reddy and Amy C. Justice

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2148

  3. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 700–708, Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun and Soko Setoguchi

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2146

  4. Off-label prescribing patterns of antidepressants in children and adolescents

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 137–144, Euni Lee, Anna R. Teschemaker, Rosemary Johann-Liang, Gina Bazemore, Martin Yoon, Kye-Sik Shim, Marlon Daniel, Jerome Pittman and Anthony K. Wutoh

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2145

  5. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1088–1097, Andrea V. Margulis, Niteesh K. Choudhry, Colin R. Dormuth and Sebastian Schneeweiss

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2144

  6. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2136

  7. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 763–771, Chia-Hsuin Chang, Hsi-Chieh Chen, Jou-Wei Lin, Chuei-Wen Kuo, Wen-Yi Shau and Mei-Shu Lai

    Article first published online : 25 MAY 2011, DOI: 10.1002/pds.2140

  8. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2153

  9. Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 9, September 2011, Pages: 922–929, Anthony P. Nunes, Kate L. Lapane, Martin A. Weinstock and VATTC Trial Group

    Article first published online : 18 JUN 2011, DOI: 10.1002/pds.2142

  10. Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 643–652, Shuko Nojiri, Kenichi Gemba, Keisuke Aoe, Katsuya Kato, Takuhiro Yamaguchi, Tsugumichi Sato, Kiyoshi Kubota and Takumi Kishimoto

    Article first published online : 18 MAR 2011, DOI: 10.1002/pds.2123

  11. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 626–634, Dominik Rottenkolber, Sven Schmiedl, Marietta Rottenkolber, Katrin Farker, Karen Saljé, Silke Mueller, Marion Hippius, Petra A. Thuermann, Joerg Hasford and for the Net of Regional Pharmacovigilance Centers

    Article first published online : 8 MAR 2011, DOI: 10.1002/pds.2118

  12. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 488–496, Alessandro Nobili, Carlotta Franchi, Luca Pasina, Mauro Tettamanti, Marta Baviera, Lara Monesi, Carla Roncaglioni, Emma Riva, Ugo Lucca, Angela Bortolotti, Ida Fortino and Luca Merlino

    Article first published online : 24 JAN 2011, DOI: 10.1002/pds.2108

  13. Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 608–618, Beate Aurich-Barrera, Lynda Wilton, David Brown and Saad Shakir

    Article first published online : 23 FEB 2011, DOI: 10.1002/pds.2105

  14. Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 497–505, Carlotta Franchi, Ugo Lucca, Mauro Tettamanti, Emma Riva, Ida Fortino, Angela Bortolotti, Luca Merlino, Luca Pasina and Alessandro Nobili

    Article first published online : 23 MAR 2011, DOI: 10.1002/pds.2124

  15. Benefit-risk assessment: to quantify or not to quantify, that is the question

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 653–656, Zhong Yuan, Bennett Levitan and Jesse A. Berlin

    Article first published online : 27 APR 2011, DOI: 10.1002/pds.2149

  16. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 506–513, Fatemeh Chalabianloo, Aud Berstad, Jan Schjøtt, Bettina Riedel, Ågot Irgens and Erik Florvaag

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2134

  17. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 514–522, Johanna Jyrkkä, Hannes Enlund, Piia Lavikainen, Raimo Sulkava and Sirpa Hartikainen

    Article first published online : 9 FEB 2011, DOI: 10.1002/pds.2116

  18. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Article first published online : 17 JUN 2011, DOI: 10.1002/pds.2132

  19. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 747–753, Pernelle Noize, Haleh Bagheri, Geneviève Durrieu, Françoise Haramburu, Nicholas Moore, Patrick Giraud, Michel Galinier, Jacques Pourrat and Jean-Louis Montastruc

    Article first published online : 16 MAR 2011, DOI: 10.1002/pds.2128

  20. Drug prescriptions of adults with adolescent depression in a community sample

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 130–136, Aivar Päären, Lars von Knorring, Ulf Jonsson, Hannes Bohman, Gunilla Olsson and Anne-Liis von Knorring

    Article first published online : 26 APR 2011, DOI: 10.1002/pds.2120